Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Data by

Global Data

22

Revenue 2014

Daiichi Sankyo

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Daiichi Sankyo's 2012 sales performance.

Hookipa Biotech appoints new global head of research and development

Hookipa Biotech appoints new global head of research and development

Hookipa Biotech appoints new global head of research and development. Dr Igor Matushansky joins the firm from Daiichi Sankyo. ... Previously global head of translational development for oncology at Daiichi Sankyo, Matushansky has experience in early

Xarelto beats aspirin for recurrent blood clots

Xarelto beats aspirin for recurrent blood clots rival NOAC Eliquis (apixaban) from Pfizer and Bristol-Myers Squibb (BMS) with 42.5%, well ahead of third place Pradaxa (dabigatran) from Boehringer Ingelheim and Daiichi Sankyo's new entrant Savaysa

Deal Watch January 2017

Deal Watch January 2017 Kite Pharma. Daiichi Sankyo. Licence. Cellular cancer therapy axicabtagene ciloleucel (KTE-C19).

Kite bags $90m upfront in two Asian deals for lead CAR-T drug

Kite bags $90m upfront in two Asian deals for lead CAR-T drug Partners with Daiichi Sankyo and Fosun Pharma to focus in on non-Hodgkin lymphoma. ... Kite's Japanese partnership is with Daiichi Sankyo and will see Kite receive $50m upfront and $200m in development and commercial milestone payments in return for

Deal Watch October 2016

Deal Watch October 2016 $53m. 4.1. GI 2015. Daiichi Sankyo. Movantik US co-pro. $825m. GI 2014.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Global Data Data by GlobalData

GlobalData is the premier source of research and consulting solutions for the pharmaceutical and medical device industries. With the combined expertise of more than 600 researchers, market analysts and consultants, we deliver high-quality, accurate and transparent industry insight that helps our clients to achieve growth and increase business value.

To find out more about how our research and consulting solutions can help you, please visit healthcare.globaldata.com

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

Precision medicine and the changing role of the healthcare professional
The growth of precision medicine introduces a shift away from treating the population as a whole, to treating each patient as an individual. How does this change the role of...
How will Sustainability and Transformation Plans (STPs) change the NHS commissioning landscape?
Sue Thomas and Paul Midgley, of Wilmington Healthcare, take a look at new commissioning structures and what they mean for pharma...
eyeforpharma Barcelona 2017 highlights: Industry at the brink of transformation
Hear what Anthill's delegates reported back from the biggest eyeforpharma Barcelona yet....

Infographics